Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 3
2008 2
2009 2
2010 3
2011 5
2012 1
2013 6
2014 3
2015 9
2016 9
2017 19
2018 14
2019 9
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK, Singh A, Ganta S, Amiji MM. Iyer AK, et al. Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21. Adv Drug Deliv Rev. 2013. PMID: 23880506 Review.
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.
Alsaab HO, Sau S, Alzhrani RM, Cheriyan VT, Polin LA, Vaishampayan U, Rishi AK, Iyer AK. Alsaab HO, et al. Among authors: Iyer AK. Biomaterials. 2018 Nov;183:280-294. doi: 10.1016/j.biomaterials.2018.08.053. Epub 2018 Aug 30. Biomaterials. 2018. PMID: 30179778 Free PMC article.
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
Sharma AK, Gothwal A, Kesharwani P, Alsaab H, Iyer AK, Gupta U. Sharma AK, et al. Among authors: Iyer AK. Drug Discov Today. 2017 Feb;22(2):314-326. doi: 10.1016/j.drudis.2016.09.013. Epub 2016 Sep 23. Drug Discov Today. 2017. PMID: 27671487 Review.
The use of nanoscaffolds and dendrimers in tissue engineering.
Gorain B, Tekade M, Kesharwani P, Iyer AK, Kalia K, Tekade RK. Gorain B, et al. Among authors: Iyer AK. Drug Discov Today. 2017 Apr;22(4):652-664. doi: 10.1016/j.drudis.2016.12.007. Epub 2017 Feb 20. Drug Discov Today. 2017. PMID: 28219742 Review.
80 results
Jump to page
Feedback